For a long time, the likelihood of surviving pancreatic cancer has been extremely low. For patients who were diagnosed with metastatic pancreatic cancer between 2015 and 2021, about 97% died within five years of their diagnosis.
Pancreatic…

For a long time, the likelihood of surviving pancreatic cancer has been extremely low. For patients who were diagnosed with metastatic pancreatic cancer between 2015 and 2021, about 97% died within five years of their diagnosis.
Pancreatic…

Chai Discovery cofounders Josh Meier (left) and Jack Dent
Cody Pickens for Forbes
L
ast June, when AI drug discovery startup Chai Discovery was just 15 months old, it released a new model that could design antibodies. Nearly 20 pharma companies…

Imagine a train sitting at a station. Passengers have boarded, conductors have checked tickets, and everything appears ready to go. But if the engineer’s watch has stopped working, the train never departs. The doors stay open, the whistle never…

Scientists have uncovered a surprising new way the immune system fights cancer, overturning a core belief that has guided immunology for decades. The research found that when cancer cells shut down a key immune-recognition molecule called MHC…

Stethoscope on the dollars. Medical costs. Healthcare payment concept. Concept of analysis of the market and economy and interest rates
getty
Healthcare costs are rising nearly 20% for small-and mid-sized employers as employers grapple with a surge…

Illustration by Anumana // Why bring AI into a test that has been around for a hundred years? | Each of my stories includes an original artwork. Clicking on them will take you to their websites. I am grateful for all the collaborators, sharing…

With demand for personalized wellness solutions on the rise, CeliaRx is helping bring peptide therapy to a broader audience through a physician-guided telehealth platform.
Courtesy of CeliaRx
Just a few years ago, peptides were largely confined to…

In this week’s edition of InnovationRx, we look at cancer breakthroughs from the ASCO conference, Clear’s move into healthcare, Harrison.ai’s U.S. expansion, and more. To get it in your inbox, subscribe here.
Collate’s Surbhi Sarna
Cody…

Popular GLP-1 drugs including Ozempic, Wegovy, Mounjaro, and Zepbound have already transformed the treatment of type 2 diabetes and obesity. Now, new research suggests these medications may also help prevent and treat addiction across a broad…

A newly developed pill could offer a fresh approach to treating type 2 diabetes and obesity. Early research suggests it may help lower blood sugar and increase fat burning without reducing appetite or causing muscle loss, two common concerns…